GOJO® PCMX E-2 Sanitizing Lotion Soap

Manufacturer
GOJO Industries, Inc.
Effective date
2024-12-09
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:41:41

Label at a glance#

ProductGOJO PCMX E-2 Sanitizing Ltn Sp
Active ingredientCHLOROXYLENOL
Label structure7 sections

Indications and uses

Handwash to help decrease bacteria on the skin Recommended for repeated use

Dosage and administration

Wet hands Apply a small amount of product and work into a lather Rinse well and dry hands completely

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Chloroxylenol 0.3%

Purpose

OTC - PURPOSE SECTION

Antimicrobial

Uses

INDICATIONS & USAGE SECTION

  • Handwash to help decrease bacteria on the skin
  • Recommended for repeated use

Warnings

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

When using this productdo not use in or near the eyes. In case of contact, rinse eyes thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor ifirritation or rash appears and lasts

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Wet hands
  • Apply a small amount of product and work into a lather
  • Rinse well and dry hands completely

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water (Aqua), Coconut Acid, Oleic Acid, Sodium Sulfate, Ethanolamine, Cocamide MEA, Coco-Betaine, Propylene Glycol, Tetrasodium EDTA

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Product LabelProduct Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
424daadb-95de-8ece-97f5-235e3f7f0001Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
21749-457-20GOJO PCMX E-2 Sanitizing Ltn Sp2000 mL in 1 PACKAGELIQUID20002
21749-457-37GOJO PCMX E-2 Sanitizing Ltn Sp3780 mL in 1 PACKAGELIQUID37802
21749-457-50GOJO PCMX E-2 Sanitizing Ltn Sp5000 mL in 1 PACKAGELIQUID50002
21749-457-55GOJO PCMX E-2 Sanitizing Ltn Sp208000 mL in 1 PACKAGELIQUID2080002
21749-457-80GOJO PCMX E-2 Sanitizing Ltn Sp800 mL in 1 PACKAGELIQUID8002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
21749-457GOJO PCMX E-2 SANITIZING LTN SP (CHLOROXYLENOL) LIQUID [GOJO INDUSTRIES, INC.]2Current NDC, Legacy NDC, 5 package rows20241211_bb91cf7c-62a6-4163-8072-1be5ce3b6433.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
21749-45721749-457-80, 21749-457-20, 21749-457-50, 21749-457-37, 21749-457-55

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GOJO PCMX E-2 Sanitizing Ltn SpCHLOROXYLENOLGOJO Industries, Inc.bb91cf7c-62a6-4163-8072-1be5ce3b64332024-12-09WarningsExact identifier
ndc (package): 21749-457-55
ndc (package): 21749-457-37
ndc (package): 21749-457-80
ndc (package): 21749-457-50
ndc (package): 21749-457-20
ndc (product): 21749-457
ndc11 (package): 21749045720
ndc11 (package): 21749045737
ndc11 (package): 21749045750
ndc11 (package): 21749045755
ndc11 (package): 21749045780
spl id: 28dbde57-a1b2-5ad3-e063-6294a90a7998
spl set id: bb91cf7c-62a6-4163-8072-1be5ce3b6433

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.